| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Insider buying and selling activity across 114 companies in the Pharmaceuticals industry. Part of the Health Care sector.
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Aug 5, 2021 | TLRY Tilray Brands, Inc. | Kennedy Brendan87 | Director | Sell | 600,000 | $14.27 | $8,562,840.00 | -3.6% | -24.9% | -73.0% | |
| Aug 4, 2021 | LLY Eli Lilly & Co | Lilly Endowment Inc | 10% Owner | Sell | 13,458 | $265.15 | $3,568,359.54 | - | -1.8% | +18.1% | |
| Aug 4, 2021 | BHC Bausch Health Companies Inc. | De Schutter Richard U | Director | Buy | 10,000 | $25.01 | $250,123.00 | +3.3% | +3.3% | -79.6% | |
| Aug 3, 2021 | LLY Eli Lilly & Co | Lilly Endowment Inc | 10% Owner | Sell | 236,542 | $256.12 | $60,582,473.91 | - | -2.3% | +24.3% | |
| Aug 3, 2021 | BMY Bristol Myers Squibb Co | Powell Ann64 | EVP, Chief Human Resources | Sell | 23,280 | $68.57 | $1,596,309.60 | -32.8% | -14.6% | +8.6% | |
| Aug 2, 2021 | SNY Sanofi | Sanofi | 10% Owner | Buy | 66,667 | $15.00 | $1,000,005.00 | +2.2% | -0.6% | -2.7% | |
| Aug 2, 2021 | AMPH Amphastar Pharmaceuticals, Inc. | Zhou Rong59 | EVP, Production Center | Sell | 9,123 | $21.24 | $193,734.20 | -9.9% | -11.1% | +76.0% | |
| Aug 2, 2021 | BMY Bristol Myers Squibb Co | Caforio Giovanni59 | Chairman And CEO | Sell | 20,000 | $68.58 | $1,371,600.00 | -3.8% | -13.0% | +11.1% | |
| Aug 2, 2021 | ALKS Alkermes Plc. | McKeon Brian P69 | Director | Buy | 10,000 | $26.43 | $264,269.00 | New | +11.1% | -4.9% | |
| Aug 2, 2021 | AMPH Amphastar Pharmaceuticals, Inc. | Liawatidewi Yakob47 | EVP Corp Admin Center | Sell | 8,932 | $21.14 | $188,804.62 | -14.2% | -11.1% | +76.0% | |
| Jul 30, 2021 | PFE Pfizer Inc | Damico Jennifer B.58 | SVP &Controller | Sell | 2,500 | $42.86 | $107,150.00 | -17.9% | +0.9% | +21.8% | |
| Jul 30, 2021 | BMY Bristol Myers Squibb Co | Leung Sandra | EVP, General Counsel | Sell | 29,390 | $68.04 | $1,999,695.60 | -8.0% | -15.1% | +12.1% | |
| Jul 30, 2021 | BMY Bristol Myers Squibb Co | Dubow Adam63 | SVP,Chiefcompliance&Ethicsoff. | Sell | 2,466 | $67.90 | $167,441.40 | -15.2% | -15.1% | +12.1% | |
| Jul 30, 2021 | BMY Bristol Myers Squibb Co | Von Autenried Paul | EVP, Chief Information Officer | Sell | 25,000 | $68.06 | $1,701,375.00 | -17.9% | -15.1% | +12.1% | |
| Jul 30, 2021 | BMY Bristol Myers Squibb Co | Vessey Rupert53 | EVP, Research &Early Dev. | Sell | 158,393 | $68.07 | $10,782,153.64 | -65.4% | -15.1% | +12.1% | |
| Jul 30, 2021 | HIMS Hims & Hers Health, Inc. | Institutional Venture Management Xv, LLC66 | 10% Owner | Sell | 83,503 | $0.00 | - | -0.4% | 0.0% | -21.7% | |
| Jul 30, 2021 | CPIX Cumberland Pharmaceuticals Inc | Galante Joseph C47 | Director | Buy | 2,414 | $3.32 | $8,004.54 | +0.4% | -18.5% | -30.2% | |
| Jul 30, 2021 | CPIX Cumberland Pharmaceuticals Inc | Jones James53 | Director | Buy | 714 | $3.32 | $2,367.54 | +0.3% | -18.5% | -30.2% | |
| Jul 30, 2021 | CPIX Cumberland Pharmaceuticals Inc | Kazimi A J59 | Chairman And CEO | Buy | 315 | $3.27 | $1,028.85 | - | -18.5% | -30.2% | |
| Jul 30, 2021 | CPIX Cumberland Pharmaceuticals Inc | Young Caroline52 | Director | Buy | 315 | $3.27 | $1,028.85 | +0.1% | -18.5% | -30.2% | |
| Jul 30, 2021 | CPIX Cumberland Pharmaceuticals Inc | Krogulski Kenneth55 | Director | Buy | 1,785 | $3.26 | $5,826.75 | - | -18.5% | -30.2% | |
| Jul 30, 2021 | CPIX Cumberland Pharmaceuticals Inc | Cearnal Martin E47 | Sr Vp/ Chief Commercial Officer | Buy | 2,310 | $3.25 | $7,505.40 | - | -18.5% | -30.2% | |
| Jul 29, 2021 | ALKS Alkermes Plc. | Gaffin David Joseph | SVP, CLO, Alkermes, Inc. | Sell | 14,000 | $26.00 | $364,000.00 | -15.8% | +12.1% | +0.2% | |
| Jul 29, 2021 | PCRX Pacira Biosciences, Inc. | Riker Lauren Bullaro76 | Vice President, Finance | Sell | 2,500 | $60.85 | $152,121.40 | -8.7% | -14.0% | -5.9% | |
| Jul 29, 2021 | BUDZ Weed, Inc. | Breen Nicole M | Secretary/ Treasurer | Sell | 55,000 | $0.31 | $17,150.00 | - | - | - |
The blue line has two modes, toggled with the Relative and Absolute buttons:
Relative (default) shows cumulative industry performance with both the overall market and parent sector movements removed. When the line rises above 100, the industry is outperforming its sector; below 100 means underperforming. This is calculated using factor returns via weighted least squares (WLS) regression, isolating pure industry-specific behavior.
Absolute shows the total cumulative return of the industry including market and sector movement. This reflects what an investor actually experienced — an industry can show strong absolute gains even while underperforming its sector in relative terms.
Both views start at an index of 100. Other return drivers such as momentum, value, or size are deliberately retained in both modes, since these are part of what makes an industry behave the way it does and may reflect the conditions insiders are responding to.